Evaluation of novel particles as pulmonary delivery systems for insulin in rats. - Wikidata - wikimedia - TriplyDB

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

http://www.wikidata.org/entity/Q37362017

about

Advances in PEGylation of important biotech molecules: delivery aspects Trehalose and calcium exert site-specific effects on calmodulin conformation in amorphous solids.Effects of excipients on protein conformation in lyophilized solids by hydrogen/deuterium exchange mass spectrometry.Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.Role of protein stabilizers on the conformation of the unfolded state of cytochrome c and its early folding kinetics: investigation at single molecular resolution.Pulmonary drug delivery strategies: A concise, systematic review A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis.Carrier-based strategies for targeting protein and peptide drugs to the lungs.Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption.A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.Evaluation of PEG and mPEG-co-(PGA-co-PDL) microparticles loaded with sodium diclofenac.

P2860

Q28277255-230C9713-C1D9-4F43-ACE4-32A822FF91BF Q30359741-692B82FA-8413-4F45-A70A-6A380935F7EF Q30362623-52099D2A-73A8-4063-8579-8AE1A6AC7682 Q33510791-59FC30B2-62FA-4189-846F-CA3F12D28D84 Q34055756-E2F72151-88FA-4F82-B0E3-05BC3D017D6E Q35746468-FE599884-F4B8-4441-BA62-005155B9A7C3 Q35851344-48342AD2-A49B-4B82-9C49-4D9BF038154E Q36250762-A9C99599-937D-483A-AC34-77F7DE69D10F Q38168594-51C2D757-7093-4BC6-AF4C-796C1343D2C1 Q41929458-BDF0CD8F-C75B-4C90-B4EB-F42AB250332F Q42150353-6E268196-8115-46B8-9239-E90234084B15

P2860

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

http://www.wikidata.org/entity/Q37362017

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2003

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@en

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@nl

type

label

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@en

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@nl

prefLabel

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@en

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@nl

P1433

Q37362017-6F0C52E0-665A-4F2B-9024-53B4AFB6BD7E

P1476

Q37362017-B90553CB-E4FE-4370-881F-ED8725089B0F

P2093

Q37362017-19B3C0AA-6D64-478A-8D35-C8D47CC35205

Q37362017-8037C144-D329-4F58-BFF8-293734C1D984

Q37362017-8CBC8229-F792-4530-B19A-3DA93C1A96D8

Q37362017-FC9EBB50-5EF1-46C8-92AF-07D36360A1A8

P2860

Q37362017-0DE331D2-FAFC-45D0-9D18-30F085BB2CBA

Q37362017-1428D9B9-0295-41AD-BF48-8B48F6B30042

Q37362017-4124F249-DD5B-43FA-9391-CB39177F6207

Q37362017-4B6113C1-27D2-4BD6-BC22-B1168C501B2B

Q37362017-8668C263-E2CD-4107-BEF4-06BFA3B9C7D2

Q37362017-88F191D7-D621-45D7-B4C3-6494F1250782

Q37362017-9702304F-46B0-431D-B9CD-FFA663A3D781

Q37362017-AE6B8E31-AAE9-4A58-A388-67A86987356E

Q37362017-BF486D6B-5165-4ED7-BE62-A581AD158C91

Q37362017-C8D8A77D-6E43-4320-BB74-34625B319BA5

P304

Q37362017-0732140A-7A78-4271-AEFD-3E617D9A9E67

P31

Q37362017-1568649C-3A9D-438A-A769-3B14FAB6F1B0

P356

Q37362017-C45CE83B-D10A-46FD-A5BD-21FC7F269174

P433

Q37362017-61F14CAF-260D-4140-968D-07A4F73119AC

P478

Q37362017-76E82AAA-B9EE-423B-B347-26B7B7E57DA1

P577

Q37362017-76B1522C-8A12-4AFC-B4B6-7863CB26C84B

P5875

Q37362017-87C33496-B3AC-45C2-A54F-98E58C44A800

P698

Q37362017-7FCB3B93-3D68-44EE-AFC6-C75E4A7C399F

P921

Q37362017-BA261814-B37C-4C85-921B-690B7D57C18A

P932

Q37362017-A8FB7862-2686-41DE-B62F-7A2D30F8E252

P356

P1433

P1476

Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

@en

P2093

Anthony J Hickey

http://www.w3.org/2001/XMLSchema#string

Lucila Garcia-Contreras

http://www.w3.org/2001/XMLSchema#string

Steve J D Bell

http://www.w3.org/2001/XMLSchema#string

Tülin Morçöl

http://www.w3.org/2001/XMLSchema#string

P2860

Calcium phosphate nanoparticle adjuvant.

Pharmacokinetic considerations of new insulin formulations and routes of administration.

Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.

Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats.

Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats.

Immediate and short-term cellular and biochemical responses to pulmonary single-dose studies of insulin and H-MAP.

Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.

Recent advances in pulmonary drug delivery using large, porous inhaled particles.

LAGRAN program for area and moments in pharmacokinetic analysis.

P304

E9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/PS050209

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6553844

http://www.w3.org/2001/XMLSchema#string

P698

12866936

http://www.w3.org/2001/XMLSchema#string

P921

P932

2751517

http://www.w3.org/2001/XMLSchema#string